메뉴 건너뛰기




Volumn 85, Issue 3, 2013, Pages 1743-1752

Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for fabry disease by tandem mass spectrometry

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; ENZYME REPLACEMENT THERAPY; FABRY DISEASE; GALACTOSIDASES; GLOBOTRIAOSYLCERAMIDE; HEALTHY CONTROLS; LYSOSOMAL STORAGE DISORDER; MASS-TO-CHARGE RATIO; METABOLOMICS; MOLECULAR PATHOGENESIS; MULTIPLEX ANALYSIS; RELATIVE QUANTIFICATION; SPHINGOLIPIDS; SPHINGOSINE; TANDEM MASS SPECTROMETRY; THERAPEUTIC INTERVENTION; TRACE AMOUNTS; URINARY BIOMARKERS; URINARY EXCRETION;

EID: 84873381566     PISSN: 00032700     EISSN: 15206882     Source Type: Journal    
DOI: 10.1021/ac303033v     Document Type: Article
Times cited : (68)

References (53)
  • 36
    • 40749126517 scopus 로고    scopus 로고
    • In; Mehta, A. Beck, M. Sunder-Plassmann, G. Oxford PharmaGenesis: Oxford, U.K.
    • Cox, T. M. In Fabry Disease: Perspectives from 5 Years of FOS; Mehta, A.; Beck, M.; Sunder-Plassmann, G., Eds.; Oxford PharmaGenesis: Oxford, U.K., 2006
    • (2006) Fabry Disease: Perspectives from 5 Years of FOS
    • Cox, T.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.